NeuroBo Pharmaceuticals, Inc. (NRBO) Earnings
|
Expand Research on NRBO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +4.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.3% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/7/24 | Q324 | -$0.55 | $0.00 | -$0.55 | N/A | N/A | N/A |  | | Details | |
| 8/15/24 | Q224 | -$1.85 | $0.00 | -$1.85 | N/A | N/A | N/A | | | Details | |
| 3/29/24 | Q423 | N/A | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23  |
Q323 | -$0.09 | -$0.11 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 8/15/23 | Q223 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/24/23 | Q123 | N/A | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/3/23 | Q422 | N/A | -$1.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/16/22 | Q322 | N/A | -$5.10 | N/A | N/A | N/A | N/A | N/A | N/A |
